ANSAIT
Parkinson, in Giappone primo trattamento con le staminali, ma gli esperti invitano alla prudenza
Limpe-Dismov, "Efficacia incerta, diffidare da chi offre cure fuori da sperimentazioni"
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
Limpe-Dismov, "Efficacia incerta, diffidare da chi offre cure fuori da sperimentazioni"
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.